4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-027093
CEO and CFO bought 2,000 shares at $10.55 ($21,100)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-08-04 | Purchase | +2,000 | $10.55 | $21,100 | 5,290,177 | D |
| Open-market purchases · 2,000 sh · avg $10.55 · $21,100 | |||||||
Loading xslF345X05/ownership.xml…